Skip to main content
. 2018 May 22;2018(5):CD011977. doi: 10.1002/14651858.CD011977.pub2

Aose 2006.

Methods Study design: RCT
Study grouping: parallel group; no further details provided
Exclusions after randomisation: not reported
Losses to follow‐up: not reported
How missing data were handled: not reported
Reported power size calculation? no
Participants Baseline characteristics
Blue‐light filtering IOL group
  • Number of participants: number of people (number of eyes): not reported

  • Sex (number of women/number of men): not reported

  • Age: not reported


Non‐blue‐light filtering IOL group 1
  • Number of participants: number of people (number of eyes): not reported

  • Sex (number of women/number of men): not reported

  • Age: not reported


Non‐blue‐light filtering IOL group 2
  • Number of participants: number of people (number of eyes): not reported

  • Sex (number of women/number of men): not reported

  • Age: not reported


Non‐blue‐light filtering IOL group 3
  • Number of participants: number of people (number of eyes): not reported

  • Sex (number of women/number of men): not reported

  • Age: not reported


Inclusion criteria: not reported
Exclusion criteria: not reported
Comparison of study groups at baseline: not reported
Interventions Intervention characteristics
Blue‐light filtering IOL
  • Type of IOL: YA‐60BB (Hoya)


Non‐blue‐light filtering IOL 1
  • Type of IOL: SA60AT (Alcon)


Non‐blue‐light filtering IOL 2
  • Type of IOL: MA60BM (Alcon)


Non‐blue‐light filtering IOL 3
  • Type of IOL: VA60BB (Hoya)

Outcomes Refractive error, visual acuity, IOL tilt, IOL decentration, intraocular pressure, corneal endothelial cell loss and aqueous flare at three months postoperatively
Identification Sponsorship source:
Funding sources: none
Declaration of interest: none for all authors
Country: not reported
Setting: not reported
Comments:
Date study conducted: not reported
Trial registration number: not reported
Contacting study investigators: study authors not contacted; no additional information used for review
Date study conducted: not reported
First author's name: M Aose
Institution: Ophthalmology, Dokkyo University School of Medicine, Tochigi, Japan
Email: not reported
Address: not reported
Notes ARVO conference abstract
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Judgement comment: not reported how list was generated. Study is described as “randomised” but with no further details
Allocation concealment (selection bias) Unclear risk Judgement comment: not reported how allocation administered. Study is described as “randomised” but with no further details
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Judgement comment: no information on masking. We assume that in absence of reporting, participants and personnel were not masked.
Blinding of outcome assessment (detection bias) 
 All outcomes High risk Judgement comment: no information on masking. We assume that in absence of reporting, the outcome assessors were not masked.
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Judgement comment: follow‐up not reported
Selective reporting (reporting bias) Unclear risk Judgement comment: no access to protocol or trials registry entry
Other bias Low risk Judgement comment: no other apparent sources of bias